Literature DB >> 25641099

Progress in vaccine development.

Peter Michael Moyle1.   

Abstract

Vaccination has a proven record as one of the most effective medical approaches to prevent the spread of infectious diseases. Traditional vaccine approaches involve the administration of whole killed or weakened microorganisms to stimulate protective immune responses. Such approaches deliver many microbial components, some of which contribute to protective immunity, and assist in guiding the type of immune response that is elicited. Despite their impeccable record, these approaches have failed to yield vaccines for many important infectious organisms. This has prompted a move towards more defined vaccines ('subunit vaccines'), where individual protective components are administered. This unit provides an overview of the components that are used for the development of modern vaccines including: an introduction to different vaccine types (whole organism, protein/peptide, polysaccharide, conjugate, and DNA vaccines); techniques for identifying subunit antigens; vaccine delivery systems; and immunostimulatory agents ('adjuvants'), which are fundamental for the development of effective subunit vaccines.
Copyright © 2015 John Wiley & Sons, Inc.

Entities:  

Keywords:  DNA vaccines; Toll-like receptors; adjuvants; antigen identification; conjugate vaccines; peptide vaccines; polysaccharide vaccines; recombinant vaccines; subunit vaccines

Mesh:

Substances:

Year:  2015        PMID: 25641099     DOI: 10.1002/9780471729259.mc1801s36

Source DB:  PubMed          Journal:  Curr Protoc Microbiol


  7 in total

Review 1.  An Update on "Reverse Vaccinology": The Pathway from Genomes and Epitope Predictions to Tailored, Recombinant Vaccines.

Authors:  Marcin Michalik; Bardya Djahanschiri; Jack C Leo; Dirk Linke
Journal:  Methods Mol Biol       Date:  2022

2.  Harnessing the Digital Exhaust: Incorporating wellness into the pharma model.

Authors:  Justin M Wright; Graham B Jones
Journal:  Digit Biomark       Date:  2018-04-11

3.  Controlled Covalent Conjugation of a Tuberculosis Subunit Antigen (ID93) to Liposome Improved In Vitro Th1-Type Cytokine Recall Responses in Human Whole Blood.

Authors:  Babatunde Ayodeji Adeagbo; Akintunde Oluseto Akinlalu; Tony Phan; Jeff Guderian; Gerhardt Boukes; Elize Willenburg; Caryn Fenner; Oluseye Oladotun Bolaji; Christopher B Fox
Journal:  ACS Omega       Date:  2020-11-20

Review 4.  Vaccine development to control the rising scourge of antibiotic-resistant Acinetobacter baumannii: a systematic review.

Authors:  Ravinder Singh; Neena Capalash; Prince Sharma
Journal:  3 Biotech       Date:  2022-03-02       Impact factor: 2.406

5.  Natural Brucella melitensis Infection and Rev. 1 Vaccination Induce Specific Brucella O-Polysaccharide Antibodies Involved in Complement Mediated Brucella Cell Killing.

Authors:  Shubham Mathur; Menachem Banai; Dani Cohen
Journal:  Vaccines (Basel)       Date:  2022-02-17

6.  Strain Dependent Genetic Networks for Antibiotic-Sensitivity in a Bacterial Pathogen with a Large Pan-Genome.

Authors:  Tim van Opijnen; Sandra Dedrick; José Bento
Journal:  PLoS Pathog       Date:  2016-09-08       Impact factor: 6.823

7.  Epitope-Based Peptide Vaccine against Glycoprotein G of Nipah Henipavirus Using Immunoinformatics Approaches.

Authors:  Arwa A Mohammed; Shaza W Shantier; Mujahed I Mustafa; Hind K Osman; Hashim E Elmansi; Isam-Aldin A Osman; Rawan A Mohammed; Fatima A Abdelrhman; Mihad E Elnnewery; Einas M Yousif; Marwa M Mustafa; Nafisa M Elfadol; Alaa I Abdalla; Eiman Mahmoud; Ahmed A Yagaub; Yassir A Ahmed; Mohamed A Hassan
Journal:  J Immunol Res       Date:  2020-04-22       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.